Transforming Outdated Post-Acute and In-Home Care

For millions of patients, receiving essential treatments like IV hydration, antibiotics, or blood transfusions has long meant stressful, expensive hospital visits. Beyond the inconvenience, these visits often lead to higher costs, increased risk of infection, and overburdened hospital resources.

Enter Vellum Health, an Austin-based healthcare startup on a mission to bring high-quality IV access and infusion care directly to patients wherever they are - in their homes, skilled nursing facilities, or at the bedside in acute-care settings. Led by CEO Tyler Payne, Vellum recently closed its Series A funding round, backed by FCA Venture Partners, Green Park & Golf Ventures, and key angel investors.

---

A Modern Mobile Care Platform

Vellum Health has built a unified platform that merges multiple regional vascular access and mobile infusion providers into one seamless, scalable system. By focusing on smart deployment of peripheral IVs, midlines, PICC lines, infusions, and even bedside blood transfusions, Vellum streamlines critical services that typically require hospital infrastructure.

The company pairs this clinical expertise with advanced technology. Its AI-enhanced coordination tools integrate deeply into electronic health record (EHR) systems and intelligently route care requests. This allows hospitals and nursing facilities to identify patients who need urgent IV care, get rapid bedside support, and avoid unnecessary admissions.

Behind this approach lies a critical insight that healthcare founders can learn from: operational pain points that are often viewed as cost centers can be transformed into major growth engines if addressed with a platform mindset. 

Vellum is a perfect example. By turning fragmented, manual, labor-intensive IV services into a unified, data-driven platform, the company shifts what was previously a logistical nightmare into a strategic revenue stream. Startups that adopt this mindset early build operational leverage and brand trust - two advantages that compound as they scale. Rather than seeing delivery purely as a service, Vellum treats it as infrastructure, enabling faster expansion into new regions and adjacent services. The Series A funding isn’t just about growing service volume; it’s about building the backbone for decentralized, value-based healthcare at scale.

---

Strong Momentum and a Patient-First Approach

Vellum Health’s rapid adoption shows that hospitals, skilled nursing facilities, and patients are all seeking alternatives to traditional hospital-based infusions. By eliminating many of the delays and complications that plague post-acute transitions, Vellum improves outcomes, reduces readmissions, and lowers total care costs.

Providers gain operational relief and can redirect in-house resources to higher-acuity cases. Patients get faster access to treatments without leaving home or risking exposure to hospital-based infections. And payers benefit from a more cost-effective, data-transparent model.

---

Funding to Accelerate Nationwide Expansion

With its new Series A funding, Vellum plans to expand its clinical network and mobile teams nationally. The company will deepen integrations with EHR vendors to further reduce manual workflows and ensure rapid, seamless scheduling. Investments in advanced analytics and AI will also improve proactive patient identification and optimize resource allocation.

The capital will support expanded training and quality assurance efforts, ensuring clinical standards remain high as the company scales to meet rising demand across multiple states.

---

Leadership Driving the Vision

Under Tyler Payne’s leadership, Vellum has brought together an experienced team of clinicians, technologists, and operational leaders. Their focus on integrating human expertise with technology allows the company to maintain high-touch, personalized care while achieving the efficiencies needed to grow rapidly.

Their collective mission centers on delivering hospital-level trust and quality anywhere - without sacrificing speed or safety.

---

The Future of Bedside and Home-Based Care

The healthcare industry is increasingly moving toward decentralized, patient-centered delivery models. As value-based care continues to gain traction, solutions like Vellum’s mobile IV platform will become essential to reducing hospital readmissions and controlling costs while keeping patients healthier at home.

Vellum’s Series A round signals investor confidence in this shift and underscores the company’s role in leading it. By enabling hospitals and skilled nursing facilities to extend their clinical reach without expanding physical footprints, Vellum offers a powerful blueprint for the future of post-acute and in-home care.